Adage Capital Partners Gp, L.L.C. Dice Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.19 - $22.1 $395,700 - $663,000	-30,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$14.54 - $25.02 $3.2 Million - $5.5 Million	-220,000 Reduced 88.0%	30,000 $574,000
Q3 2021 Nov 15, 2021	BUY	$31.92 - $37.0 $7.98 Million - $9.25 Million	250,000 New	250,000 $8.19 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.